A case of de novo 18p deletion syndrome with panhypopituitarism
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Deletion on the short arm of chromosome 18 is a rare disorder characterized by intellectual disability, growth retardation, and craniofacial malformations (such as prominent ears, microcephaly, ptosis, and a round face). The phenotypic spectrum is wide, encompassing a range of abnormalities from minor congenital malformations to holoprosencephaly. We present a case of a 2-year-old girl with ptosis, a round face, broad neck with low posterior hairline, short stature, and panhypopituitarism. She underwent ventilation tube insertion for recurrent otitis media with effusion. Brain magnetic resonance imaging showed an ectopic posterior pituitary gland and a shallow, small sella turcica with poor visualization of the pituitary stalk. Cytogenetic and chromosomal microarray analysis revealed a de novo deletion on the short arm of chromosome 18 (arr 18p11.32p11.21[136,227–15,099,116]x1). She has been treated with recombinant human growth hormone (GH) therapy since the age of 6 months after diagnosis of GH deficiency. Her growth rate has improved without any side effects from the GH treatment. This case expands the phenotypic spectrum of 18p deletion syndrome and emphasizes the positive impact of GH therapy on linear growth in this syndrome characterized by growth deficiency. Further studies are required to define the genotype-phenotype correlation according to size and loci of the deletion in 18p deletion syndrome and to predict prognosis.
Abstract
Deletion on the short arm of chromosome 18 is a rare disorder characterized by intellectual disability, growth retardation, and craniofacial malformations (such as prominent ears, microcephaly, ptosis, and a round face). The phenotypic spectrum is wide, encompassing a range of abnormalities from minor congenital malformations to holoprosencephaly. We present a case of a 2-year-old girl with ptosis, a round face, broad neck with low posterior hairline, short stature, and panhypopituitarism. She underwent ventilation tube insertion for recurrent otitis media with effusion. Brain magnetic resonance imaging showed an ectopic posterior pituitary gland and a shallow, small sella turcica with poor visualization of the pituitary stalk. Cytogenetic and chromosomal microarray analysis revealed a de novo deletion on the short arm of chromosome 18 (arr 18p11.32p11.21[136,227–15,099,116]x1). She has been treated with recombinant human growth hormone (GH) therapy since the age of 6 months after diagnosis of GH deficiency. Her growth rate has improved without any side effects from the GH treatment. This case expands the phenotypic spectrum of 18p deletion syndrome and emphasizes the positive impact of GH therapy on linear growth in this syndrome characterized by growth deficiency. Further studies are required to define the genotype-phenotype correlation according to size and loci of the deletion in 18p deletion syndrome and to predict prognosis.
참고문헌 (16)
- Turleau C, "Monosomy 18p", Orphanet J Rare Dis, 3, pp.4~ (2008)
- Rao VB, "18p deletion syndrome with a 45, XY, t (14; 18) (p11;q11.2), -18, karyotype", Ann Genet, 44, pp.187~190 (2001)
- Brenk CH, "Towards mapping phenotypical traits in 18p- syndrome by array-based comparative genomic hybridisation and fluorescent in situ hybridisation", Eur J Hum Genet, 15, pp.35~44 (2007)
- Wester U, "Clinical and molecular characterization of individuals with 18p deletion: a genotype-phenotype correlation", Am J Med Genet A, 140, pp.1164~1171 (2006)
- Kasasbeh FA, "Deletion of 18p Syndrome", Lab Med, 42, pp.436~438 (2011)
- Brandl J, "A chromosome supplement to the London Dysmorphology Database", J Med Genet, 24, pp.497~498 (1987)
- Hasi-Zogaj M, "A review of 18p deletions", Am J Med Genet C Semin Med Genet, 169, pp.251~264 (2015)
- de Grouchy J, "Clinical atlas of human chromosomes", pp.308~313 (1984), John Wiley &Sons
- Bellfield EJ, "Anterior pituitary Aplasia in an infant with ring chromosome 18p deletion", Case Rep Endocrinol, 2016, pp.2853178~ (2016)
- Artman HG, "18p- syndrome and hypopituitarism", J Med Genet, 29, pp.671~672 (1992)
- Schaub RL, "Molecular characterization of 18p deletions: evidence for a breakpoint cluster", Genet Med, 4, pp.15~19 (2002)
- Di Bella D, "Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28", Nat Genet, 42, pp.313~321 (2010)
- Glas J, "PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background", PLoS One, 7, pp.e33682~ (2012)
- Campbell GR, "The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis", J Biol Chem, 279, pp.48197~48204 (2004)
- Sun H, "Genotype-phenotype analysis, neuropsychological assessment, and growth hormone response in a patient with 18p deletion syndrome", Cytogenet Genome Res, 154, pp.71~78 (2018)
- Rogers DG, "Response to growth hormone treatment in a patient with 18p-syndrome", J Pediatr Endocrinol Metab, 25, pp.1023~1025 (2012)